Hawkins 2Q 2026: Revenue $313.82M, Net income $27.78M, EPS $1.34— 10-Q Summary

What happened

Hawkins reported second-quarter 2026 sales of $313.82 million, up 11.9% from the prior-year quarter. Net income rose 22.9% to $27.78 million and diluted earnings per share increased 24.1% to $1.34. Organic sales growth was 11%.

Confirmed

Global impact / market context

Profit grew faster than sales, which means Hawkins kept more profit from each sale as costs rose more slowly than revenue. All segments grew, and acquisitions like Eagle Labs expand Texas distribution and manufacturing capacity, supporting future sales.

Analyst inference

Results show broad demand across water treatment, food and health sciences, and industrial solutions, with water treatment leading at 16% growth. Management expects cash flows and available resources to fund operations and capital spending needs for at least the next 12 months.

Analyst inference

What to watch

1. Hawkins added Aqua-Chem and Symonds during fiscal 2027 and acquired Eagle Labs after quarter-end to expand Texas distribution and manufacturing capabilities. Confirmed
2. Watch whether management gives specific financial targets for the newly acquired Aqua-Chem, Symonds, and Eagle Labs businesses, including expected sales contributions and integration costs. Proposed
3. Watch whether water treatment volume and pricing gains continue, since that segment drove the strongest growth and supports profit per sale if costs stay controlled. Analyst inference

Evidence

• Original source link unavailable